相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia
Mahmoud Al-Kofahi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Dose Predictions for Drug Design
Tristan S. Maurer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats
Yingfan Hu et al.
SCIENTIFIC REPORTS (2019)
Applications of machine learning in drug discovery and development
Jessica Vamathevan et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Model-Informed Drug Development: Current US Regulatory Practice and Future Considerations
Yaning Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Pharmacokinetics and Pharmacodynamics of Curcumin in regulating anti-inflammatory and epigenetic gene expression
Sarandeep S. S. Boyanapalli et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2018)
Machine learning in chemoinformatics and drug discovery
Yu-Chen Lo et al.
DRUG DISCOVERY TODAY (2018)
Automated Scale Reduction of Nonlinear QSP Models With an Illustrative Application to a Bone Biology System
Chihiro Hasegawa et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Drug-Target Kinetics in Drug Discovery
Peter J. Tonge
ACS CHEMICAL NEUROSCIENCE (2018)
Novel CNS drug discovery and development approach: model-based integration to predict neuro-pharmacokinetics and pharmacodynamics
Elizabeth C. M. de lange et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective
Harvey Wong et al.
DRUG DISCOVERY TODAY (2017)
Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen
Xiaonan Li et al.
DRUG METABOLISM AND DISPOSITION (2017)
Validation of Early Human Dose Prediction: A Key Metric for Compound Progression in Drug Discovery
Ken M. Page
MOLECULAR PHARMACEUTICS (2016)
Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective
H. M. Jones et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges
Kashyap Patel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Plasma and cerebrospinal fluid concentrations of ibuprofen in pediatric patients and antipyretic effect: Pharmacokinetic-pharmacodynamic modeling analysis
Ronly Har-Even et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
A High-Throughput Cell-Based Method to Predict the Unbound Drug Fraction in the Brain
Andre Mateus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Model-based drug discovery: implementation and impact
Sandra A. G. Visser et al.
DRUG DISCOVERY TODAY (2013)
The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives
Tjerk Bueters et al.
DRUG DISCOVERY TODAY (2013)
Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics
Kenneth H. Grime et al.
MOLECULAR PHARMACEUTICS (2013)
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
H. M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies
Yuan Chen et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2012)
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
Paul Morgan et al.
DRUG DISCOVERY TODAY (2012)
Mechanism-based PK-PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans
Jasper Stevens et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms
Hongming Chen et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
Strategic Use of Plasma and Microsome Binding To Exploit in Vitro Clearance in Early Drug Discovery
George Chang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans
In-hwan Baek et al.
ARCHIVES OF PHARMACAL RESEARCH (2008)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of mode rate-to-strong bases (vol 94, pg 1259, 2007)
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Physiologically-based pharmacokinetic Modeling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and mitterions (vol 95, pg 1238, 2007)
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Predicting the active doses in humans from animal studies: A novel approach in oncology
M. Rocchetti et al.
EUROPEAN JOURNAL OF CANCER (2007)
Morphine in postoperative patients: Pharmacokinetics and pharmacodynamics of metabolites
Jean Xavier Mazoit et al.
ANESTHESIA AND ANALGESIA (2007)
Investigation of the effects of herbal medicines on warfarin response in healthy subjects: A population pharmacokinetic-pharmacodynamic modeling approach
Xuemin Jiang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery
N Parrott et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children
N Gupta et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2005)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents
M Simeoni et al.
CANCER RESEARCH (2004)
A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis
G Pillai et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
B Agoram et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)